XPH ETF: State Street SPDR S&P Pharmaceuticals ETF - Price, Holdings & Analysis
State Street SPDR S&P Pharmaceuticals ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About State Street SPDR S&P Pharmaceuticals ETF
What is the current price of XPH?
The latest XPH price is $54.72. The 52-week range is $35.22–$58.84. XPH has returned 29.7% over the past 52 weeks.
What is the expense ratio for XPH?
XPH's annual expense ratio is 0.35%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.
Does XPH pay dividends?
Yes, XPH pays a 0.85% dividend yield. The last ex-dividend date was 2026-06-25. View full dividend history in the Dividends section.
What are the top holdings of XPH?
XPH's largest holdings are Enliven Therapeutics, Inc. (2.4%), Liquidia Corporation (2.4%), Corcept Therapeutics Incorporated (2.4%) (combined weight: 7.2%). The fund holds 60 total positions. View the complete portfolio breakdown in the Holdings section.
How does XPH compare to similar ETFs?
Compare XPH (0.35% expense ratio, $313M AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.